Skip to main content
BUDZ
OTC Life Sciences

Pre-Revenue WEED, INC. Narrows Q1 Net Loss to $(175K), Still Faces Funding Challenges

feedReported by Wiseek News
Sentiment info
Negative
Importance info
7
Price
$0.031
Mkt Cap
$4.628M
52W Low
$0.016
52W High
$0.085
Market data snapshot near publication time

summarizeSummary

WEED, INC. reported its first-quarter 2026 results, showing no revenue and a net loss of $(175,256), or $(0.001) per share. This update follows the company's recent 10-K filing, which highlighted a going concern opinion, significant losses, and critically low cash reserves. While the company remains pre-revenue and unprofitable, the reported net loss represents a substantial improvement from $(440,455) in the prior-year quarter, indicating some progress in cost control or operational efficiency. For a micro-cap company facing severe financial challenges, these results provide an updated view of its burn rate. Investors will need to monitor any developments in revenue generation from its hemp product plans, progress in genomic studies, or successful funding initiatives, as the company's commercial outlook explicitly states plans are "pending funding."

At the time of this announcement, BUDZ was trading at $0.03 on OTC in the Life Sciences sector, with a market capitalization of approximately $4.6M. The 52-week trading range was $0.02 to $0.08. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed BUDZ - Latest Insights

BUDZ
May 15, 2026, 4:23 PM EDT
Source: Wiseek News
Importance Score:
7
BUDZ
May 15, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
9
BUDZ
Apr 09, 2026, 2:30 PM EDT
Source: Access Newswire
Importance Score:
9
BUDZ
Apr 08, 2026, 2:58 PM EDT
Filing Type: 10-K
Importance Score:
9